Uncategorized

Effects of Treatment as Prevention¨ evaluated in first of its kind analysis

In what’s believed to be a first of its kind analysis, BC-CfE researchers evaluated patient reported HIV care experiences and therapeutic outcomes prior to, and after, implementation of BC’s Treatment as Prevention¨ (TasP¨) designed Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) program.

Effects of Treatment as Prevention¨ evaluated in first of its kind analysis Read More »

BC-CfE researchers present their findings at CAHR 2022

In late April the Canadian Association for HIV Research (CAHR) held its annual conference. With more than 1,000 members, CAHR is the leading organization of HIV/AIDS researchers in Canada. The theme for this year’s virtual conference was “Striving Towards Equity and Flourishing in the HIV Response”. In choosing the theme, organizers of the conference compared the decades-long fight for equitable distribution of antiretroviral therapy (ART) to the distribution of COVID-19 vaccines, and the massive disparities seen between high and low-income countries in both.

BC-CfE researchers present their findings at CAHR 2022 Read More »

Treatment Optimization of Psychosis (TOP) and how BC is improving care for those living with schizophrenia

Schizophrenia affects more than 24 million people worldwide according to the World Health Organization. Common symptoms include thinking disorder, delusions, hallucinations, and negative syndrome, which induces severe loss of interest and social isolation. The term schizophrenia literally means “a splitting of the mind” and was coined in 1908 by Swiss psychiatrist Dr. Paul Eugen Bleuler.

Treatment Optimization of Psychosis (TOP) and how BC is improving care for those living with schizophrenia Read More »

BC-CfE urges heightened caution due to monkeypox

Health authorities in Canada, the US, Spain, Portugal, and the UK have issued alerts over possible outbreaks of monkeypox. This viral infection is usually spread by respiratory transmission, but in these latest cases certain characteristics point towards fluid contact as a possible mode of transmission. A majority of these monkeypox cases are among men who have sex with men.

BC-CfE urges heightened caution due to monkeypox Read More »

Chapter 1: Pre-HAART (1992 – 1996)

In the 30 years since its inception in 1992, the advancements made by the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) have transformed HIV from a rapidly fatal disease, to a chronic and manageable illness that is highly, and easily, preventable. By helping shape local and global policy with its Treatment as Prevention¨ strategy, the BC-CfE has quite literally revolutionized HIV/AIDS care, saving and improving millions of lives worldwide.

Chapter 1: Pre-HAART (1992 – 1996) Read More »

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy

The Hepatitis C virus (HCV) is a blood borne infection and a leading cause of end-stage liver disease. The World Health Organization estimates that about 58 million people are living with chronic HCV, leading to 290,000 deaths annually due to HCV-related liver illness. Here in Canada, HCV affects a quarter of a million people. Of this quarter million, over 40% are unaware of their infection.

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy Read More »

Scroll to Top

During the Canada Post strike, the following measures have been undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office.  (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During this time, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service.